Brain TumorSymptoms, Doctors, Treatments, Advances & More
Brain Tumor Overview
Learn About Brain Tumor
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Dana-Farber Cancer Institute, Center For Neuro-Oncology
Patrick Wen is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Wen is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Wen is board certified in Neurology and Neuro-Oncology.
Cleveland Clinic Main Campus
David Peereboom is an Oncologist and a Hematologist Oncology provider practicing medicine in Cleveland, Ohio. Dr. Peereboom is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioblastoma, Glioma, Astrocytoma, and Bone Marrow Aspiration. Dr. Peereboom is board certified in United Council For Neurological Subspecialties, 2008.
Cleveland Clinic Main Campus
Samuel Chao is a Radiation Oncologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 29 years. Dr. Chao is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 52 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Astrocytoma, Glioma, Glioblastoma, and Gamma Knife Radiosurgery. Dr. Chao is board certified in American Board Of Radiology, 2007.
Summary: The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier opening with Exablate Model 4000 Type 2.0/2.1 for the treatment of NSCLC brain metastases in patients who are undergoing planned FDA approved, on-label systemic therapy utilizing immune checkpoint inhibitors.
Summary: To find a recommended dose of the combination of alpelisib and pembrolizumab that can be given to patients with metastatic breast cancer or melanoma.


